* Surgepays Inc SURG.OQ SURG.O is expected to show a
fall in
quarterly revenue when it reports results on May 13 for the
period ending March 31 2024
* The Bartlett Tennessee-based company is expected to
report a
14.0% decrease in revenue to $29.907 million from $34.78 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Surgepays Inc is for
earnings
of 20 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Surgepays
Inc is
$7.00, above its last closing price of $4.09.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.41 0.41 0.19 Missed -53.3
Sep. 30 2023 0.28 0.29 0.49 Beat 71.9
Jun. 30 2023 0.15 0.16 0.40 Beat 158.1
Mar. 31 2023 -0.03 -0.03 0.31 Beat 1,133.
3
Jan. -0.19 -0.11 0.25 Beat 317.4
1 0001
Sep. 30 2022 0.29 0.29 -0.12 Missed -141.4
Jun. 30 2022 0.00 0.01 -0.07 Missed -800
Mar. 31 2022 -0.04 -0.04 -0.10 Missed -150
This summary was machine generated May 10 at 20:19 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)